Gene · 7003
Papers2,415
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,415
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pancreatic Cancer Research beyond DNA Mutations. | Biomolecules | 2022 | 36291712 | PubTator, text mining | PubMed |
| The Roles of microRNA miR-185 in Digestive Tract Cancers. | Noncoding RNA | 2022 | 36287119 | PubTator, text mining | PubMed |
| Role of glucose metabolism in ocular angiogenesis (Review). | Mol Med Rep | 2022 | 36281924 | PubTator, text mining | PubMed |
| Screening saikosaponin d (SSd)-producing endophytic fungi from Bupleurum scorzonerifolium Willd. | World J Microbiol Biotechnol | 2022 | 36280622 | PubTator, text mining | PubMed |
| LncRNA KCNQ1OT1 predicts further cerebral events in patients with transient ischemic attack. | Front Pharmacol | 2022 | 36278219 | PubTator, text mining | PubMed |
| Yap1 modulates cardiomyocyte hypertrophy via impaired mitochondrial biogenesis in response to chronic mechanical stress overload. | Theranostics | 2022 | 36276651 | PubTator, text mining | PubMed |
| SRC-RAC1 signaling drives drug resistance to BRAF inhibition in de-differentiated cutaneous melanomas. | NPJ Precis Oncol | 2022 | 36271142 | PubTator, text mining | PubMed |
| OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer. | Oncogene | 2022 | 36271031 | PubTator, text mining | PubMed |
| Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement. | Mater Today Bio | 2022 | 36267139 | PubTator, text mining | PubMed |
| Identification of miRNA-mRNA-TFs regulatory network and crucial pathways involved in asthma through advanced systems biology approaches. | PLoS One | 2022 | 36264868 | PubTator, text mining | PubMed |
| Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma. | Evid Based Complement Alternat Med | 2022 | 36248415 | PubTator, text mining | PubMed |
| Promotion of Melanoma Cell Proliferation by Cyclic Straining through Regulatory Morphogenesis. | Int J Mol Sci | 2022 | 36233186 | PubTator, text mining | PubMed |
| mRNA Capture Sequencing and RT-qPCR for the Detection of Pathognomonic, Novel, and Secondary Fusion Transcripts in FFPE Tissue: A Sarcoma Showcase. | Int J Mol Sci | 2022 | 36232302 | PubTator, text mining | PubMed |
| The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study. | Cancers (Basel) | 2022 | 36230758 | PubTator, text mining | PubMed |
| Molecular Classification of Hepatocellular Carcinoma Using Wnt-Hippo Signaling Pathway-Related Genes. | Cancers (Basel) | 2022 | 36230503 | PubTator, text mining | PubMed |
| Transcriptomic profiling of sporadic Alzheimer's disease patients. | Mol Brain | 2022 | 36224601 | PubTator, text mining | PubMed |
| Upper cortical layer-driven network impairment in schizophrenia. | Sci Adv | 2022 | 36223459 | PubTator, text mining | PubMed |
| CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation. | Cell Biosci | 2022 | 36210463 | PubTator, text mining | PubMed |
| Identification and functional analysis of variants of MYH6 gene promoter in isolated ventricular septal defects. | BMC Med Genomics | 2022 | 36209093 | PubTator, text mining | PubMed |
| Next Generation Sequencing for Potential Regulated Genes and Micro-RNAs of Early Growth Response-1 in the Esophageal Squamous Cell Carcinoma. | Protein J | 2022 | 36207572 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7003/papers?page=35